
Doctors have successfully treated porphyria using an innovative ‘gene-silencing’ drug. Speaking to the BBC, Professor David Rees, from King’s College …
Roche will pay $450 million to acquire the RNA specialist firm Santaris Pharma in order to once again begin research …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

